FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085864690> ?p ?o ?g. }

• W2085864690 endingPage "359" @default.
• W2085864690 startingPage "353" @default.
• W2085864690 abstract "Background: Type 2 diabetes mellitus (T2DM) with the presence of metabolic syndrome (MetS) carries increased risk for cardiovascular disease. Adjunctive exenatide treatment in patients with T2DM is associated with improvements in glycemic control coupled with progressive weight reduction. We evaluated exenatide use on glycosylated hemoglobin A1c (HbA1c) and cardiometabolic risk factors in patients with T2DM and MetS in a single clinical practice setting. Methods: A retrospective analysis of clinical data extracted from the records of 176 adult patients with T2DM and MetS (106 women, 70 men) who received exenatide along with existing therapeutic regimes from 2005 to 2007 was performed. HbA1c, lipid profiles, blood pressure, and anthropometric measures were evaluated at baseline and after 16 (±4) weeks of exenatide therapy. Results: Mean HbA1c was significantly reduced from baseline in 16 weeks (P < 0.001), with 68% of patients achieving HbA1c <7%. Total, high-density lipoprotein-, and low-density lipoprotein-cholesterol levels decreased significantly. This decline was not attributable to changes in lipid-lowering agents. Significant reductions were also noted in body mass index, mean body weight, and abdominal girth (AG) with the addition of exenatide. Additional analyses showed 76% of subjects lost weight. Lessening of AG was much more pronounced in female compared with male subjects with diabetes (P < 0.032). No consistent changes in blood pressure were observed. Conclusions: We found that addition of exenatide to an existing treatment regimen in patients with T2DM and MetS resulted in significant reductions in HbA1c along with decline in lipids, AG, and body weight. This indicates improvement in these patients' metabolic profiles." @default.
• W2085864690 created "2016-06-24" @default.
• W2085864690 creator A5028955634 @default.
• W2085864690 creator A5050207230 @default.
• W2085864690 creator A5051058058 @default.
• W2085864690 creator A5068311949 @default.
• W2085864690 creator A5081003342 @default.
• W2085864690 creator A5084616395 @default.
• W2085864690 date "2009-06-01" @default.
• W2085864690 modified "2023-09-25" @default.
• W2085864690 title "Improved Glycemic Control and Reduction of Cardiometabolic Risk Factors in Subjects with Type 2 Diabetes and Metabolic Syndrome Treated with Exenatide in a Clinical Practice Setting" @default.
• W2085864690 cites W1823466767 @default.
• W2085864690 cites W1964227153 @default.
• W2085864690 cites W1964478407 @default.
• W2085864690 cites W1966214201 @default.
• W2085864690 cites W1984740259 @default.
• W2085864690 cites W1986085856 @default.
• W2085864690 cites W1999627357 @default.
• W2085864690 cites W2007914298 @default.
• W2085864690 cites W2014789180 @default.
• W2085864690 cites W2019784051 @default.
• W2085864690 cites W2025840130 @default.
• W2085864690 cites W2044144587 @default.
• W2085864690 cites W2057651652 @default.
• W2085864690 cites W2060449981 @default.
• W2085864690 cites W2062883844 @default.
• W2085864690 cites W2065867087 @default.
• W2085864690 cites W2086485180 @default.
• W2085864690 cites W2093738306 @default.
• W2085864690 cites W2107732097 @default.
• W2085864690 cites W2115707749 @default.
• W2085864690 cites W2123289485 @default.
• W2085864690 cites W2132257534 @default.
• W2085864690 cites W2135179675 @default.
• W2085864690 cites W2151701113 @default.
• W2085864690 cites W2154904247 @default.
• W2085864690 cites W2162055998 @default.
• W2085864690 cites W2162934281 @default.
• W2085864690 cites W2164416879 @default.
• W2085864690 cites W2165698647 @default.
• W2085864690 cites W2167984392 @default.
• W2085864690 cites W2168536185 @default.
• W2085864690 cites W2344620176 @default.
• W2085864690 cites W4238251256 @default.
• W2085864690 cites W4247770508 @default.
• W2085864690 cites W4249714536 @default.
• W2085864690 cites W4252910375 @default.
• W2085864690 doi "https://doi.org/10.1089/dia.2008.0090" @default.
• W2085864690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19459763" @default.
• W2085864690 hasPublicationYear "2009" @default.
• W2085864690 type Work @default.
• W2085864690 sameAs 2085864690 @default.
• W2085864690 citedByCount "27" @default.
• W2085864690 countsByYear W20858646902012 @default.
• W2085864690 countsByYear W20858646902013 @default.
• W2085864690 countsByYear W20858646902014 @default.
• W2085864690 countsByYear W20858646902017 @default.
• W2085864690 countsByYear W20858646902018 @default.
• W2085864690 countsByYear W20858646902019 @default.
• W2085864690 countsByYear W20858646902020 @default.
• W2085864690 countsByYear W20858646902021 @default.
• W2085864690 countsByYear W20858646902022 @default.
• W2085864690 crossrefType "journal-article" @default.
• W2085864690 hasAuthorship W2085864690A5028955634 @default.
• W2085864690 hasAuthorship W2085864690A5050207230 @default.
• W2085864690 hasAuthorship W2085864690A5051058058 @default.
• W2085864690 hasAuthorship W2085864690A5068311949 @default.
• W2085864690 hasAuthorship W2085864690A5081003342 @default.
• W2085864690 hasAuthorship W2085864690A5084616395 @default.
• W2085864690 hasConcept C126322002 @default.
• W2085864690 hasConcept C134018914 @default.
• W2085864690 hasConcept C2777180221 @default.
• W2085864690 hasConcept C2780221984 @default.
• W2085864690 hasConcept C2780473172 @default.
• W2085864690 hasConcept C2780533449 @default.
• W2085864690 hasConcept C2780578515 @default.
• W2085864690 hasConcept C2781413609 @default.
• W2085864690 hasConcept C2910068830 @default.
• W2085864690 hasConcept C511355011 @default.
• W2085864690 hasConcept C544821477 @default.
• W2085864690 hasConcept C555293320 @default.
• W2085864690 hasConcept C71924100 @default.
• W2085864690 hasConcept C84393581 @default.
• W2085864690 hasConceptScore W2085864690C126322002 @default.
• W2085864690 hasConceptScore W2085864690C134018914 @default.
• W2085864690 hasConceptScore W2085864690C2777180221 @default.
• W2085864690 hasConceptScore W2085864690C2780221984 @default.
• W2085864690 hasConceptScore W2085864690C2780473172 @default.
• W2085864690 hasConceptScore W2085864690C2780533449 @default.
• W2085864690 hasConceptScore W2085864690C2780578515 @default.
• W2085864690 hasConceptScore W2085864690C2781413609 @default.
• W2085864690 hasConceptScore W2085864690C2910068830 @default.
• W2085864690 hasConceptScore W2085864690C511355011 @default.
• W2085864690 hasConceptScore W2085864690C544821477 @default.
• W2085864690 hasConceptScore W2085864690C555293320 @default.
• W2085864690 hasConceptScore W2085864690C71924100 @default.
• W2085864690 hasConceptScore W2085864690C84393581 @default.
• W2085864690 hasIssue "6" @default.

• next